title: Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]).
authors.affiliation: Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. p.desauvagenolting@amc.uva.nl
authors.forename: Pernette R W
authors.initials: PR
authors.lastname: de Sauvage Nolting
authors.forename: Rudolf J A
authors.initials: RJ
authors.lastname: Buirma
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Hutten
authors.forename: John J P
authors.initials: JJ
authors.lastname: Kastelein
mesh_terms: D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001053:Apolipoproteins / Q000097:blood / Q000187:drug effects; D003402:Creatine Kinase / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood / Q000187:drug effects; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced; D019821:Simvastatin / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors; D000637:Transaminases / Q000187:drug effects; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D001053:Apolipoproteins; D008074:Lipoproteins; D014280:Triglycerides; D019821:Simvastatin; D000637:Transaminases; D003402:Creatine Kinase